Enteral omega-3 fatty acid, γ-linolenic acid, and antioxidant supplementation in acute lung injury

JAMA

Volumn 306, Issue 14, 2011, Pages 1574-1581

  Rice, Todd W ^a   Wheeler, Arthur P ^a   Thompson, B Taylor ^b   DeBoisblanc, Bennett P ^c   Steingrub, Jay ^d   Rock, Peter ^e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE LUNG INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80054003232     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1435     Document Type: Article

References (30)

1. Bernard GR. Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med. 2005;172(7):798-806.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334-1349. (Pubitemid 30408719)
3. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol. 2000; 22(4):401-404. (Pubitemid 30343338)
4. Caironi P, Ichinose F, Liu R, Jones RC, Bloch KD, Zapol WM.5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury. Am J Respir Crit Care Med. 2005;172(3):334-343. (Pubitemid 41026144)
5. Gust R, Kozlowski JK, Stephenson AH, Schuster DP. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am J Respir Crit Care Med. 1999; 160(4):1165-1170. (Pubitemid 29487455)
6. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-1308.
7. Calder PC. n-3 fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids. 2004;39(12):1147-1161.
8. Prescott SM, Stenson WF. Fish oil fix. Nat Med. 2005;11(6):596-598. (Pubitemid 40868295)
9. Kumar KV, Rao SM, Gayani R, Mohan IK, Naidu MU. Oxidant stress and essential fatty acids in patients with risk and established ARDS. Clin Chim Acta. 2000;298(1-2):111-120. (Pubitemid 30392459)
10. Johnson MM, Swan DD, Surette ME, et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997;127(8):1435-1444. (Pubitemid 27323451)
11. Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000;130(8):1925-1931. (Pubitemid 30497522)
12. Gadek JE, DeMichele SJ, Karlstad MD, et al Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gammalinolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med. 1999; 27(8):1409-1420. (Pubitemid 29406926)
13. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34(4):1033-1038.
14. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34(9):2325-2333. (Pubitemid 44260016)
15. Bernard GR, Artigas A, Brigham KL, et al The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149(3, pt 1):818-824.
16. National Heart, Lung, and Blood Institute (NHLBI). Early versus delayed enteral feeding to treat people with acute lung injury or acute respiratory distress syndrome (The EDEN Study). ClinicalTrials.com Web site. http://www.clinicaltrials.gov/ct2/show/NCT00883948?term=ALI+feeding&rank=2. Accessed March 16, 2011.
17. Wiedemann HP, Wheeler AP, Bernard GR, et al National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354(24):2564-2575. (Pubitemid 43882352)
18. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999; 354(9193):1851-1858.
19. DeMets DL, Ware JH. Asymmetric group sequential boundaries for monitoring clinical trials. Biometrika. 1982;69:661-663.
20. Brower RG, Lanken PN, MacIntyre N, et al National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive endexpiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004; 351(4):327-336.
21. Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: a systematic review. JAMA. 2005;294(17):2203-2209. (Pubitemid 41571138)
22. al-Saady NM, Blackmore CM, Bennett ED. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med. 1989;15(5): 290-295. (Pubitemid 19213222)
23. Finfer S, Chittock DR, Su SY, et al NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl JMed. 2009; 360(13):1283-1297.
24. Parsons PE, Eisner MD, Thompson BT, et al NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):1-6, 230-232.
25. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem. 2006;52(12):2265-2272. (Pubitemid 44925001)
26. Skeaff CM, Hodson L, McKenzie JE. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr. 2006;136(3):565-569. (Pubitemid 43363736)
27. Pacht ER, DeMichele SJ, Nelson JL, Hart J, Wennberg AK, Gadek JE. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med. 2003;31(2):491-500. (Pubitemid 36232946)
28. Chilton FH, Patel M, Fonteh AN, Hubbard WC, Triggiani M. Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production: influence of duration and dosage. J Clin Invest. 1993; 91(1):115-122. (Pubitemid 23037262)
29. Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care. 2010;14(1):R5.
30. Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med. 2008; 34(8):1411-1420.